Celltrion Inc.

Celltrion Inc. is a South Korean biopharmaceutical company that specializes in developing and manufacturing biotechnology-based medications, particularly biosimilars and monoclonal antibodies. Biosimilars are treatments that are highly similar to already approved biological drugs and can offer more affordable options for patients. Celltrion focuses on areas such as cancer, autoimmune diseases, and infectious diseases. By leveraging advanced biomanufacturing technologies, the company aims to provide innovative therapies that improve patient access to essential medications while maintaining high safety and efficacy standards.